Last reviewed · How we verify

NCT03477669: Colic

Infantile Colic: Study of the Efficacy of Lactobacillus GG (ATCC 53103) Plus Chamomile in Breastfeeding Infants

Terminated NA Last updated 25 August 2023
What this trial tests

NA trial testing chamomile/probiotic arm in Infantile Colic in 1 participant. Terminated before completion.

Timeline
18 May 2018
Primary endpoint
25 February 2019
25 February 2019

Quick facts

Lead sponsorUniversity of Nebraska
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment1
Start date18 May 2018
Primary completion25 February 2019
Estimated completion25 February 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Nebraska

Who can join

Adults 3 Weeks to 16 Weeks, any sex, with Infantile Colic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to determine the efficacy of a product combining the probiotic Lactobacillus GG and chamomile in treating infantile colic in exclusively breast fed infants. The study will be performed as a 4 week, placebo controlled, pilot trial with a one week run in period. Thirty subjects will be randomly assigned to each group for a total enrollment of 60 infants.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Infantile Colic

Currently open trials in the same condition.

Other University of Nebraska trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03477669.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing